Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

LIC Housing Finance - Q4FY22 Result Update - Fixed rate liabilities could cushion NIM - BUY

Posted On: 2022-06-24 13:16:59 (Time Zone: IST)


Mr. Gaurav Jani - Research Analyst at Prabhudas Lilladher Pvt. Ltd.

Quick Pointers:

- NII beat estimates by 13% driven by better margins; loan growth was weaker.

- Asset quality improved due to higher recoveries; OTR pool was stable QoQ.

LIC Housing Finance (LICHF) saw a good quarter with a positive surprise on PAT led by beat on all fronts barring loan growth, that was a miss as volumes were impacted due to third covid wave. The company guided that disbursals could grow by 15% in FY23 and builder loans could see an uptick that might contribute 5-10% to credit flow. NII was ahead due to higher NIM driven by lower funding cost. Benefit of borrowing cost could continue, that might cushion NIM considering that fixed rate liabilities contribute 53% and interest rates could harden. Asset quality improved with GNPA/NNPA reducing QoQ by 40bps each led by better recoveries. LICHF performed well in H2FY22 while valuation at 0.8x is attractive. We maintain multiple at 1.0x FY24 ABV but slightly raise TP to Rs435. Upgrade from ACCUMULATE to BUY.

Earnings beat driven by better PPoP and lower provisions: NII was higher at Rs16.3bn (PLe Rs14.4bn) due to NIM beat as loan growth was softer at 8.2% YoY (PLe 10%). Disbursals were weaker at Rs193bn (PLe Rs228bn). Repayments at Rs116bn too were higher. NIM surprised positively at 2.7% (PLe 2.4%) owing to lower funding cost. Other income was stronger at Rs1.1bn while opex was better at Rs2.5bn. PPoP was ahead at Rs14.9bn (PLe Rs12.4bn) led by better NII and other income and lower opex. While provisions were controlled at Rs1.8bn (PLe Rs2.5bn), gross and net stage-3 was lower and improved QoQ by 40bps each to 4.6%/2.6%. PCR increased QoQ from 39.7% to 43.0% which was a positive. PAT was Rs11.2bn (PLe Rs7.4bn).

Third covid wave impacted credit flow; outlook better: Disbursals were hit owing to third covid wave that affected operations. Individual continued to drive most of the credit flow and retail home now contributes 81.3% to total loans. The management is confident that disbursals could grow by 15% in FY23E as competitive intensity has reduced driven by lower systemic liquidity. There are signs of a real estate upcycle and hence the builder segment could contribute 5-10% to incremental business. Asset quality improved QoQ due to better collection efficiency. There were recoveries of Rs3.5bn in the builder portfolio of which Rs700mn was from the written-off pool. Restructured portfolio was stable QoQ at 3.1% and the split between project and retail is 50:50.

Higher proportion of fixed rate liabilities to cushion margins: NCD which are fixed rate in nature, make up for 53% of borrowings while 95% of assets are floating. This could benefit LICHF in a hardening interest rate environment as increase in yields could outpace rise in funding cost. Liabilities worth Rs250bn are expected to mature in FY23E and incremental funding cost could be range between 6.5-7.0% which would be lower than existing NCD cost of 7.4%. Assuming slippages in FY23 and FY24 would be controlled, NIM could either remain stable or improve from hereon. We have projected NIM for FY23/24E to remain stable at FY22 levels near 2.3%.

Shares of LIC Housing Finance Limited was last trading in BSE at Rs. 311.95 as compared to the previous close of Rs. 307.00. The total number of shares traded during the day was 70575 in over 2359 trades.

The stock hit an intraday high of Rs. 312.50 and intraday low of 304.70. The net turnover during the day was Rs. 21794481.00.


Click here to send ur comments or to feedback@equitybulls.com

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Gladiator Stocks - Minda Industries - ICICI Direct

Reliance Industries - Company Update - In fine fettle amidst global uncertainty - BUY

Sector Update - Sugar - ICICI Direct

Initiating Coverage - Hindustan Aeronautics Ltd - ICICI Direct

Rallis India - Company Update - Margin pressure likely to persist in near term..!! - Upgrade to 'BUY'

Indoco Remedies - Q4FY22 Result Update - In-line quarter; strong revenue guidance for US & EU mkt - Upgrade to 'BUY'

Indraprastha Gas - Q4FY22 Result Update - Impressive performance - BUY

KEC International - Annual Report Analysis - Healthy outlook across business segment - Accumulate

Westlife Development - Q4FY22 Result Update - Approaching the tipping point; Buy for LT Gains

Reliance Research downgrades Bajaj Auto to Sell

NOCIL - Q4FY22 Result Update - Strong operating performance amidst challenges - BUY

Gujarat Gas - Company Update - Deftly negotiating through tough times - BUY

Orient Electric - Gaining market share via innovation: initiate with ADD - ICICI Securities

Manappuram Finance - Q4FY22 Result Update - Intense Competition Put Pressure on Yields - BUY

Derivatives Weekly View - June 24, 2022 - ICICI Direct

Stock Tales - Newgen Software - ICICI Direct

Weekly Report - June 25, 2022 - Mr. Mitul Shah - Head of Research at Reliance securities

Gladiator Stocks - Bosch - ICICI Direct

Management Meet Update - Sheela Foam - ICICI Direct

Gladiator Stocks - Mahindra & Mahindra - ICICI Direct

Banks - Modifications to PPI and its impact on cards - Negligible impact, if any, for stocks under coverage

Navneet Education - Q4FY22 Result Update - Growth levers in place - BUY

MPC Minutes: Jun-22: All eyes on inflation - Acuité Ratings

Nazara Technologies - Management Meet Update - Breaking through the ESports landscape - BUY

Sector update - Quick Service Restaurants - YES Securities

JK Lakshmi Cement - Q4FY22 Result Update - Strong performance; Valuations drive upgrade - Accumulate

Would it be wise to invest in a home early in your career?

Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY

Dhanuka Agritech - Management Meet Update - 1Q likely to be subdued; all hopes pinned on the monsoons - BUY

BUY Ipca Laboratories - Q4FY22 Result Update - Weak exports; gradual recovery

Acuité expects India's current account deficit to widen to more than USD 90 bn in FY23 - Acuité Macro Pulse

Inflationary concerns will continue to weigh on the pace of economic revival in FY23 - Acuité Macroeconomic Performance index

City Union Bank - Q4FY22 Result Update - Asset quality on the mend - BUY

Banks - BNPL - Early results are not that exciting as yet - Kotak

Acuité expects FY23 GDP growth estimate at 7.5% - Acuité Macro Pulse - Growth - May-22 Edition

Base factor pushes up IIP in Apr-22 to an 8-month high - Acuité Ratings

India Strategy & Q4FY22 Review - Long term growth prospects to overshadow near term uncertainties

India Equity Strategy - Quarterly flipbook: Q4FY22-Cost inflation driving downgrades

FMCG - D2C is here to stay; omni-channel the way forward - HDFC Securities

Automobile Sector - Monthly Quick View - May'22 - Steady Performance Improvement, backed by Gradual Rural Recovery

BFSI - New normal rate cycle; brace for transmission effects - HDFC Securities

SBI Cards and Payment Services - BUY - TP Rs. 1260 - YES SECURITIES

RBI frontloads rate hike amid increased inflationary headwinds - Acuité Ratings

Monetary Policy June 2022 - Axis MF Views

RBI Monetary Policy View - Mr. Dhiraj Relli, MD & CEO, HDFC Securities

Monetary Policy - entering the red zone - Anuj Puri, ANAROCK

Mr. Murali Ramakrishnan, MD &CEO, South Indian Bank on RBI Monetary Policy

Comments on RBI's MPC Policy Jun'22 - Acuité Ratings

Views on RBI Monetary Policy - June 2022

Bayer Cropscience - Q4FY22 Result Update - Healthy all round performance - BUY


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020